Diabetes, Metabolic Syndrome and Obesity
Volume 15, 2022 - Issue
ORIGINAL RESEARCH
MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients
Xiaoman Chen1 Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China;2 Infectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
https://orcid.org/0000-0002-4073-8144View further author information
https://orcid.org/0000-0002-4073-8144View further author information, , , & 